Innovotech Announces AGM Results and Stock Option Grants
Edmonton, AB -- July 16, 2024 -- NewsGenie -- Innovotech Inc. (TSX-V:IOT) held its annual general and special meeting on July 16, 2024, where shareholders voted in favor of all resolutions. James Timourian, Karen Farkas, David Tam, Julie Wright, and Craig Milne were re-elected as directors.
D&H Group LLP was approved as the company's auditor for the upcoming fiscal year. An Omnibus Security Based Compensation Plan was adopted to facilitate flexible, performance-based rewards.
Innovotech's board approved granting 250,000 incentive stock options at $0.20 per share to the five directors (50,000 each). These options expire on July 15, 2029, and are priced above market to emphasize performance and future growth.
Craig Milne, CEO of Innovotech Inc., can be reached at +1-604-239-1819 or craig.milne@innovotech.ca. Innovotech is a Canadian biotechnology company with proprietary intellectual property, focusing on contract research and providing testing devices in microbiology. More details at www.innovotech.ca.
Forward-Looking Statements Disclaimer: This release contains forward-looking statements subject to risks and uncertainties. Actual results may vary. The Company is not obligated to update these statements.